DCGI approves KEYTRUDA to treat triple negative breast cancer, renal cell carcinoma EP News Bureau Oct 26, 2023 KEYTRUDA is now approved for 14 indications across eight tumour types in India
FDA approves new therapy for triple negative breast cancer that has spread, not responded to other… EP News Bureau Apr 23, 2020 The FDA granted approval of Trodelvy to Immunomedics
